SavedAdd your journal

Journals / Türk Fizyoterapi ve Rehabilitasyon / 2014 / Cilt: 25 - Sayı: 3

A COMPARISON OF PULMONARY FUNCTION AND RESPIRATORY MUSCLE STRENGTH BETWEEN BREAST CANCER SURVIVORS AND HEALTHY SUBJECTS

MEME KANSERİ OLAN KADINLARDA VE SAĞLIKLI KİŞİLERDE PULMONER FONKSİYONLAR VE SOLUNUM KAS KUVVETİNİN KARŞILAŞTIRILMASI

NACİYE VARDAR YAĞLI
Gül ŞENER
MELDA SAĞLAM
Deniz İNCE İNAL
EBRU ÇALIK KÜTÜKCÜ
Hülya ARIKAN
Sema SAVCI
Kadri ALTUNDAĞ
Tezer KUTLUK
Pages
119–123
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to the results of the study, pulmonary function testing in patients with breast cancer is affected whereas respiratory muscle strength was preserved.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Breast cancer is the most commonly diagnosed cancer in women in Turkey as well as all over the world.
📊
Key Findings & Data:Methods: A total of 40 women, 20 women with breast cancer (Stage I and II, age: 43.6 ± 4.7 years, disease duration: 5.3±0.4 years) and 20 healthy volunteers (age: 40.1±8.3 years), were included in the study.
💡
Conclusion & Impact:Conclusion: According to the results of the study, pulmonary function testing in patients with breast cancer is affected whereas respiratory muscle strength was preserved.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Breast cancer is the most commonly diagnosed cancer in women in Turkey as well as all over the world. Treatments may affect respiratory function. The purpose of the study was to compare pulmonary function and respiratory muscle strength in women with breast cancer and healthy subjects. Methods: A total of 40 women, 20 women with breast cancer (Stage I and II, age: 43.6 ± 4.7 years, disease duration: 5.3±0.4 years) and 20 healthy volunteers (age: 40.1±8.3 years), were included in the study. Subjects physical and demographic characteristics were record- ed. Time from the diagnosis and medical treatments were recorded. Pulmonary function testing was performed. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio, peak expiratory flow rate (PEF) and forced expiratory flow from 25% to 75% (FEF25-75%) were recorded. Inspiratory and expiratory muscle strength (MIP and MEP, respectively) was measured using a portable mouth pressure device. Results: Breast cancer patients FEV1, FEV1/FVC ratio, PEF, and FEF25-75% values were significantly lower than those of healthy subjects (p<0.05). There were no statistically signif- icant differences in MIP and MEP between the groups (p>0.05). Conclusion: According to the results of the study, pulmonary function testing in patients with breast cancer is affected whereas respiratory muscle strength was preserved. Assess- ment of pulmonary function is thought to be necessary in individuals with breast cancer beginning from the diagnosis of the disease.

Özet

Amaç: Meme kanseri dünyada ve Türkiyede kadınlarda en sık tanı alan kanser tipidir. Yapılan tedaviler, solunum fonksiyonlarını etkileyebilmektedir. Bu çalışmanın amacı, meme kanseri olan kadınlar ve sağlıklı kişilerle solunum fonksiyonlarının ve solunum kas kuvvetinin karşılaştırılmasıydı. Yöntemler: Çalışmaya 20 meme kanserli kadın hasta (Evre I ve II, yaş: 43.6±4.7 yıl, hastalık süresi: 5.3±0.4 yıl) ve 20 sağlıklı birey (yaş: 40.1±8.3 yıl) olmak üzere toplam 40 birey alındı. Bireylerin fiziksel ve demografik özellikleri kaydedildi. Meme kanserli olgularda tanı süresi, aldıkları medikal tedaviler kaydedildi. Bireylere solunum fonksiyon testi yapıldı. Zorlu vital kapasite (FVC), birinci saniyedeki zorlu ekspiratuar volüm (FEV1), FEV1/FVC oranı, tepe akım hızı (PEF) ve zorlu ekspiratuar akımın % 25-75i (FEF%25-75) kaydedildi. Solunum kas kuvveti, taşınabilir ağız basıncı ölçüm cihazı ile maksimal inspiratuar ve ekspiratuar basınç (MİP ve MEP) ölçümü ile, değerlendirildi. Sonuçlar: Meme kanserli olguların FEV1, FEV1/FVC oranı, PEF ve FEF%25-75 değerleri sağlıklı olgulardan anlamlı olarak daha düşüktü (p 0.05). Tartışma: Çalışmanın sonuçlarına göre meme kanserli bireylerde solunum fonksiyonlarının etkilendiği buna karşılık solunum kas kuvvetinin korunduğu belirlendi. Meme kanserli bireylerin solunum fonksiyonlarının tanı aşamasından itibaren değerlendirilmesinin gerekli olduğu düşünülmektedir.

🔖

Cite This Article

YAĞLI, N. V., ŞENER, G., SAĞLAM, M., İNAL, D. İ., KÜTÜKCÜ, E. Ç., ARIKAN, H., SAVCI, S., ALTUNDAĞ, K., KUTLUK, T. (2014). A COMPARISON OF PULMONARY FUNCTION AND RESPIRATORY MUSCLE STRENGTH BETWEEN BREAST CANCER SURVIVORS AND HEALTHY SUBJECTS. Türk Fizyoterapi ve Rehabilitasyon, Cilt: 25 - Sayı: 3, 119–123. https://ajindex.com/articles/418771

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cherniack RM, Abrams J, Kalica AR. NHLBI Workshop summary. Pulmonary disease associated with breast cancer therapy. Am J Respir Crit Care Med. 1994;150(4):1169-73
  2. Furnival CM. Breast cancer: current issues in diagnosis and tre- atment. Aust N Z J Surg. 1997;67(1):47-58
  3. Spyropoulou D, Leotsinidis M, Tsiamita M, Spiropoulos K, Kar- damakis D. Pulmonary function testing in women with breast cancer treated with radiotherapy and chemotherapy. In Vivo. 2009;23(5):867-71
  4. Hardman PD, Tweeddale PM, Kerr GR, Anderson ED, Rodger A. The effect of pulmonary function of local and loco-regional irra- diation for breast cancer. Radiother Oncol. 1994;30 (1):33-42
  5. Lund MB, Myhre KI, Melsom H, Johansen B. The effect on pulmo- nary function of tangential field technique in radiotherapy for carcinoma of the breast. Br J Radiol. 1991;64 (762):520-3
  6. Theuws JC, Muller SH, Seppenwoolde Y, Kwa SL, Boersma LJ, Hart GA, et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study. J Clin Oncol. 1999;17(10):3091-100
  7. Gomide LB, Filho JT, Matheus JP, Milani JG, Carrara HH, dos Reis FJ. The long-term impact of breast radiotherapy on dyspnea and pulmonary function. Breast J. 2009;15(5): 560-1
  8. İnal İD, Savcı S, Sağlam M, Boşnak Güçlü M, Arıkan H, Çöplü L. Kronik obstrüktif akciğer hastalarında sigara öyküsü ve fonksiyonel kapasite arasındaki ilişki. Fizyoter Rehabil. 2011;22 (1):39- 43
  9. Miller A. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1992;146(5 Pt 1):1368-9
  10. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999;32(6):703-17
  11. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166 (4):518-624
  12. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969;99(5):696-702
  13. Rutqvist LE, Rose C, Cavallin-Stahl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol. 2003;42(5-6):532-45
  14. Reidunsdatter RJ, Rannestad T, Frengen J, Frykholm G, Lundgren S. Early effects of contemporary breast radiation on health-related quality of life - predictors of radiotherapy-related fatigue. Acta Oncol. 2011;50(8):1175-82
  15. Ooi GC, Kwong DL, Ho JC, Lock DT, Chan FL, Lam WK et al. Pulmonary sequelae of treatment for breast canc